Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Amedisys Inc
- Orthofix Medical Inc.
- Janux Therapeutics, Inc.
Updated Jul 16, 2026
CAPPS VICKIE L has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $62K. Historical track record: 2/5 stars across 3 tracked purchases.
| Role | Insider |
|---|---|
| Notability | 20/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★☆☆☆ (2/5) |
|---|---|
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 6667% |
| 90-day win rate | 0% |
| Avg 5-day return | -427.31% |
| Avg 30-day return | -42.61% |
| Avg 90-day return | -2185.39% |
| Best 30-day return | +40.42% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-13 | JANX | Janux Therapeutics, Inc. | A — Grant or award | 5.5K | $0.00 | |
| 2026-06-12 | OFIX | Orthofix Medical Inc. | A — Grant or award | 15.0K | $0.00 | |
| 2026-03-10 | OFIX | Orthofix Medical Inc. | P — Open-market purchase | 2.4K | $12.45 | $30K |
| 2026-03-10 | OFIX | Orthofix Medical Inc. | P — Open-market purchase | 100 | $12.44 | $1K |
| 2026-03-10 | OFIX | Orthofix Medical Inc. | P — Open-market purchase | 2.5K | $12.48 | $31K |
| 2025-08-14 | AMED | AMEDISYS INC | D — Derivative transaction | 9.8K | — | |
| 2025-06-18 | OFIX | Orthofix Medical Inc. | A — Grant or award | 18.8K | $0.00 | |
| 2025-06-11 | JANX | Janux Therapeutics, Inc. | A — Grant or award | 3.8K | $0.00 | |
| 2025-05-03 | AMED | AMEDISYS INC | A — Grant or award | 1.7K | $0.00 | |
| 2024-11-07 | JANX | Janux Therapeutics, Inc. | J — Other acquisition / disposition | 2.3K | $0.00 |
CAPPS VICKIE L is a corporate insider — currently tracked as Insider of Janux Therapeutics, Inc. (JANX). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 3 open-market purchases ($62K) and 0 open-market sales () across all tracked filings.
Across 3 tracked purchases, CAPPS VICKIE L averaged -42.6% avg 30-day return with a 6667% 30-day win rate. InsiderAlpha rates the track record at 2/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live CAPPS VICKIE L profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.